Atlas Trials

An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial

Clinical trial NCT00534456 · TERMINATED

Trial details

NCT number
NCT00534456
Sponsor
Amgen
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
AnemiaCardiovascular DiseaseCongestive Heart FailureHeart FailureVentricular Dysfunction
Start date
2007-01-01
Primary completion
2007-10-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.